Prevascar in African Continental Group Scarring
NCT01115868
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Scarring
Interventions
DRUG:
Prevascar 5ng
DRUG:
Prevascar 25ng
DRUG:
Prevascar 100ng
DRUG:
Prevascar 250ng
Sponsor
Renovo